Recruiting

Spiritual Care

Sponsor:

University of Chicago

Code:

NCT07405424

Conditions

Leukemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

SCORE Intervention

Study Details

Brief summary:

This study is being done to determine if it is possible to incorporate spiritual care sessions as part of the care plan for patients hospitalized for leukemia treatment. In this study, participants will be randomly assigned to either no intervention (standard, real world inpatient spiritual care) or to receive study-specific guided spiritual sessions.

Conditions

Leukemia

Study ID

NCT07405424

Start date

Jun 20, 2026

Status verified date

Feb, 2026

Completion date

Jun 16, 2028

Anticipated

Primary completion date

Jun 16, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion criteria

  • Adults (18 years or older)
  • Diagnosis of Acute Leukemia (AML or ALL) undergoing inpatient initial therapy
  • Ability to read, understand, and speak the English language
  • Ability to understand and the willingness to sign a written informed consent document

Exclusion criteria

  • Unable to comply with spiritual care intervention
  • Relapsed or refractory acute leukemia
  • Cognitive deficits that limit participation and survey questionnaire completion

Study Design

Enrollment

70 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Supportive Care

Interventions and Outcome Measures

Arms

experimental: Spiritual Intervention Arm

Participants receive a study specific spiritual care intervention.

no intervention: No Intervention Arm

Interventions

SCORE Intervention

Participants assigned to this arm will receive regularly scheduled visits from the study spiritual care team during their hospital admission (four times within 14 days).

Primary outcome measure

  • Is it feasible to enroll patients to a spiritual intervention study? [ Time Frame: End of study (approximately 2 years) ]
  • Will patients accept using the study specific spiritual intervention? [ Time Frame: End of study (approximately 2 years) ]

Central Contacts and Locations

Central contacts

Clinical Trials Intake

1-855-702-8222cancerclinicaltrials@bsd.uchicago.edu

Locations

UChicago Medicine Comprehensive Cancer Center

Recruiting

Chicago, Illinois, United States, 60637

Contacts

Clinical Trials Intake

855-702-8222cancerclinicaltrials@bsd.uchicago.edu

Principal Investigator:

Wendy Stock

More Information

Sponsor

University of Chicago

Last update posted

Mar 4, 2026

Last verified

Feb, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by University of Chicago on 2026-03-04.